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ABSTRACT 
Psychosocial care has been shown to improve psychological and physiological 
functioning in cancer patients. However, as few as five percent of cancer patients 
engage in psychosocial care. Therefore, Study 1 of this dissertation developed 
measures of core TTM constructs (Stage of Change, Decisional Balance, Self-
Efficacy) relevant for increasing engagement in psychosocial care among individuals 
diagnosed with cancer. 
Measure development entailed qualitative methods for item development and 
refinement followed by a series of quantitative analyses. The Stage of Change measure 
was validated against external constructs such as subjective present and future well-
being. As expected, a chi-square test indicated that individuals in Action and 
Maintenance were significantly more likely to be in treatment than those in the pre-
Action stages.  
Measures for Decisional Balance and Self-Efficacy were developed using split-
half, cross-validation procedures. In these, a series of Principal Component Analyses 
(PCAs) were conducted with half of the sample to narrow the item set and explore 
factor structure, and Confirmatory Factor Analyses (CFA) were conducted on the 
second half of the sample to confirm the factor structure and item loadings. For 
Decisional Balance, PCA supported two, 8-item factors, and CFA indicated a two-
factor correlated model was the best fit to the data. For Self-efficacy, PCA supported 
two, 3-item factors, and CFA further supported this structure. Multivariate analyses 
indicated significant stage-construct relationships. 
  
Overall results supported the validity of the measures developed and laid the 
foundation for applying the TTM to psychosocial treatment acceptance among cancer 
populations. Implications for application of the TTM to cancer populations are 
discussed.         
 Given that cancer patients frequently experience considerable distress during 
diagnosis and treatment, Study 2 described the development and utilization of a 
behavioral health program for cancer patients, at a small community hospital, as well 
as provided preliminary results on program efficacy. This program was co-developed 
by individuals from a university-based clinical psychology doctoral program and a 
community hospital. The behavioral health program was comprised of a licensed, 
PhD-level clinical psychologist and seven clinical psychology doctoral students, who 
met with patients in order to accrue clinical hours. Patients were typically referred by 
their oncologists or nurses. Distress, depression, and anxiety were evaluated for a 
small subsample of participants. From the time the program was initiated, 238 patients 
between ages 18 and 95 (M = 66.4) were evaluated over a three-year period. The 
majority of patients (77.8%) were offered psychosocial care. Although 49.8% declined 
treatment, 23.6% engaged in one session and 26.6% engaged in two or more. Patients 
who were referred through the STAR Program® were more likely to engage in 
psychosocial care than those who found out about behavioral health through other 
means.          
 First, distress tracking may be improved if nurses, oncologists, and behavioral 
health providers administer measures. Second, partnerships between clinical 
psychology doctoral programs and hospitals may be mutually beneficial. Third, 
  
hospitals offering cancer treatment may benefit from obtaining STAR® certification, 
in order to generate referrals for comprehensive cancer care. These efforts can serve as 
a model for other hospitals seeking to integrate behavioral health into routine cancer 
treatment.  
Together, these two studies address the scarcity of studies on the intersection of 
cancer and mental health. As such, this work aimed to bridge the gap between the two 
disciplines, in order to prevent and treat mental health problems in cancer patients. 
Results of Study 1 may be used to guide researchers and clinicians in designing and 
implementing interventions. Study 2 methods and findings may be used to develop 
other behavioral health programs and to benchmark other integration efforts. 
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Abstract 
PURPOSE: Cancer is one of the most physically and emotionally debilitating diseases. 
Despite evidence that psychosocial care can improve psychological and physiological 
functioning, as well as increase survival rates, as few as 4.4% are willing to engage in 
psychosocial treatment. This study evaluated readiness to engage in psychosocial 
treatment by developing measures of Stage of Change, Decisional Balance, and Self-
Efficacy. METHODS: Online survey data was collected from a national sample of 475 
adults (Mage = 47.89, SD = 14.77) with cancer diagnoses. RESULTS: For Decisional 
Balance, PCA indicated two, 8-item factors (Pros α = .93; Cons α = .81). CFA 
supported a two-factor correlated model, χ2(103) = 349.563, p < .001, CFI = .928, 
RMSEA = .075. For Self-Efficacy, PCA indicated two, 3-item factors (“physical” and 
“social/emotional”; α = .83). CFA supported this structure. Multivariate analyses 
indicated significant cross-stage differences for Pros, Cons, and Self-Efficacy. 
CONCLUSION: Findings support the validity of the developed Stage of Change, 
Decisional Balance, and Self-Efficacy measures. These measures may be used to 
evaluate readiness to engage in psychosocial care for cancer patients and survivors – 
and to tailor interventions to help them progress through the stages. 
 
Keywords: cancer, psychosocial, readiness, TTM, stages of change, self-efficacy, 
decisional balance 
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As of January 1, 2014, approximately 14.5 million Americans had a history of 
cancer. In addition, the National Cancer Institute (NCI) of the National Institutes of 
Health (NIH), as well as the American Cancer Society (ACS) estimated 1.7 million 
new cancer cases in 2016. Notably, it is estimated that the cancer survivor population 
will increase to 19 million by January 1, 2024 [1], while the World Health 
Organization [2] predicted a 70% increase over the next two decades, worldwide. 
Although cancer incidence is expected to increase, the cancer death rate in the United 
States decreased by 23% between 1990 and 2012 [1]. Given the rise in cancer cases 
and the growing survivor population, there will also be increasing physical and 
emotional concerns associated with the disease and its treatment [3,4]. The 
multidimensional burden (i.e., vocational, financial, physical, interpersonal) of cancer 
undeniably makes it one of the most emotionally debilitating conditions [5]. 
 The relationship between the physical and emotional burden of cancer is 
evidently strong [5-8]. For instance, depression has been shown to increase the length 
of hospitalization in lung cancer patients undergoing thoracic surgery [9]. Further, in a 
sample head and neck cancer patients, quality of life and negative coping styles were 
related to higher levels of anxiety and depression, as well as lower levels of optimism 
[10]. Remarkably, a 10-year study of 3,080 cancer survivors revealed that those with 
depression had double the risk of all-cause mortality, compared to those without 
depression [11]. Collectively, these findings reveal the pervasiveness of mental health 
issues among cancer patients, their staggering impact on physiological outcomes [9], 
survival rates [12], and accordingly, the need to address psychological concerns [10]. 
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Psychosocial interventions, particularly in the form of evidence-based 
treatments and support groups, have been used to address a variety of cancer-related 
concerns, including quality of life [13,14], fatigue [15], pain [16], depression [17-19], 
and anxiety [20]. Further, psychosocial care may be used for increasing resilience and 
confidence, as well as for addressing fear of tumor progression [21]. Overall, this 
growing body of research has demonstrated effects largely in favor of psychosocial 
care.          
 Physiological outcome data further strengthens the case for psychosocial care 
among cancer patients. For instance, a seminal study revealed the effect of 
psychosocial treatment on survival of metastatic breast cancer patients, such that those 
who had participated in a support group were more likely to be survivors eight months 
after the intervention [22]. Notably, a more recent study revealed that pre-operative 
stress management improved immune functioning in men with prostate cancer 
undergoing radical prostatectomy [23]. Further, several studies found that 
psychosocial interventions were helpful in slowing disease progression [24-26] and 
increasing survival in cancer patients [27]. Collectively, studies support the potential 
for psychosocial interventions to improve cancer patients’ physiological profile.  
Numerous studies have explored the mechanisms and processes underlying the 
impact of psychosocial care on cancer patients’ physiological functioning. For 
instance, a recent review of 16 randomized controlled trials (RCTs) that examined 
specific therapeutic components of treatments tailored for cancer patients revealed that 
alterations in cognitions, self-efficacy, mood disturbance, pain, and self-esteem were 
most important [28]. An earlier study established correlations between verbal or 
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written expressions of emotions and levels of tumor-infiltrating cancer lymphocytes in 
melanoma, suggesting that psychosocial interventions can enhance emotional 
expression to positively affect disease course and overall physiological functioning 
[26]. Similarly, Jensen discovered that repression of negative emotions was associated 
with an aggravated course of breast cancer and that psychological variables were twice 
as effective at predicting clinical outcomes as were biological indicators [29]. 
Psychosocial interventions can also improve adherence to various difficult cancer 
treatments, which can increase survival. Altogether, compelling evidence exists for the 
role that psychosocial interventions may play in cancer patients’ physiological 
profiles.   
Despite overwhelmingly strong evidence that psychosocial interventions 
improve psychological and physiological well-being in cancer patients, reluctance to 
accept psychosocial treatment prevails. For example, a study of 132 cancer patients 
revealed that only 28% participated in psychosocial support, with 88% of respondents 
being women with a history of breast cancer (72%). However, those who utilized 
support had positive attitudes towards therapeutic interventions and a desire to cope 
more effectively with their illness [30]. A recent study of 1,777 cancer survivors 
revealed that only 4.4% used psychosocial care and alarmingly, the majority (55.1%) 
never even discussed the possibility with their oncologists. Interestingly, the 4.4% that 
used psychosocial services reported high satisfaction with how their needs were 
addressed [31]. In light of these findings, treatment engagement strategies are needed, 
particularly by way of assessing readiness to change and developing interventions.
 The Transtheoretical Model (TTM) has been found effective in assessing 
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readiness to change and in guiding interventions [32]. The TTM is an integrative and 
comprehensive model of intentional behavior change that incorporates process-
oriented variables to explain and predict how and when individuals change. TTM-
guided interventions have modified many health risk behavior changes, including 
adherence to medical protocols and treatments, such as mammography screening [33], 
medications [34, 35], blood glucose monitoring [37], and blood donation [36]. 
Therefore, it offers a promising theoretical framework for assessing readiness to 
accept psychosocial care for cancer populations.     
 Key TTM constructs include Stage of Change, Decisional Balance, and Self-
Efficacy. Stage of Change is the central organizing construct of the TTM, representing 
the temporal and readiness dimensions. As people change, they make forward stage 
progress through five identified stages: Precontemplation, Contemplation, Preparation, 
Action, and Maintenance. Accurately assessing Stage of Change is integral to the 
design and delivery of tailored behavior change interventions. Further, readiness to 
change is, in part, based on Decisional Balance. With regard to Decisional Balance, a 
stable pattern has been identified across Stages of Change for 48 different health risk 
behaviors [38]. For example, Cons are more salient than Pros in Precontemplation, 
whereas Pros are more salient than Cons in the Maintenance stage. Finally, Self-
Efficacy is defined as one’s level of confidence to successfully change a target 
behavior across challenging situations. Self-Efficacy scores are higher in later Stages 
of Change, such as those in Precontemplation reporting less confidence than those in 
Action or Maintenance [39]. As a result, Stage of Change, Decisional Balance, and 
Self-Efficacy may be used jointly to predict and facilitate behavior change. 
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 In light of previous research findings on cancer patient reluctance to utilize 
psychosocial care, assessing readiness to change is clearly warranted. Although 
previous studies have explored barriers [40] and readiness to utilize psychosocial 
treatment [41], this is the first study to apply the TTM and quantitative methodology 
to acceptance of psychosocial care among cancer patients. As such, using the TTM as 
a theoretical framework and developing measures for acceptance of psychosocial care 
may enhance treatment engagement and advance models of team-based cancer 
treatment approaches. Thus, this study assessed three TTM constructs (Stage of 
Change, Decisional Balance, and Self-Efficacy) to accepting psychosocial care as a 
part of one’s cancer treatment plan. The present study developed TTM measures that 
can be used to engage cancer patients in psychosocial care and to guide team-based 
interventions. 
METHODS 
Design 
A sequential process of measure development was used to develop measures of 
Stages of Change, Decisional Balance, and Self-efficacy [42]. A series of semi-
structured expert and research participant interviews were conducted. Item 
development was followed by exploratory, confirmatory, and external validation 
analyses. 
Item Development 
Initial item development was based on a comprehensive review of TTM 
measures for other behaviors (e.g., physical activity, high-fat diet, cigarette smoking). 
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Items were further developed from the literature on psychooncology and 
psychotherapy. 
Expert Interviews 
 Following initial development, items were refined using feedback from experts 
in behavioral health, oncology, and the TTM. First, one licensed psychologist and 
PhD-level expert in working with cancer patients in a team-based oncology setting 
participated in a semi-structured interview on issues surrounding patient engagement 
in psychosocial care and provided feedback on the proposed set of items. Next, two 
oncologists provided feedback on issues that cancer patients commonly face with 
regard to diagnosis and treatment, as well as barriers to engaging in psychosocial care. 
Finally, two PhD-level experts in the TTM reviewed the proposed set of items for 
clarity and face validity. 
Qualitative Participant Interviews 
 After expert feedback was incorporated, 12 semi-structured qualitative 
interviews were conducted with cancer patients actively recruited from a community 
hospital. The goal of these interviews was to elicit feedback on item clarity, 
acceptability, and face validity. Participants had to be over the age of 18 and had to 
have a cancer diagnosis. All interviews were conducted in private patient rooms, while 
individuals were receiving chemotherapy. Participants reviewed and signed informed 
consent forms first. No participants withdrew from the study after reviewing informed 
consent. Participants then reviewed and completed the initially developed items and 
provided oral feedback. Participant feedback was discussed with the TTM experts and 
was incorporated to generate the final version of the survey. 
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Survey Administration 
 The survey was administered using SurveyMonkey™ online survey software. 
Participants accessed the survey via an online link provided by Cint™, a targeted 
survey population and panel recruitment company. Individuals were asked to check a 
box indicating that they read the informed consent form and agreed to participate. 
They were then routed to questions on eligibility criteria (same as those for qualitative 
interviews). Eligible individuals were then linked to the full survey. Data were 
extracted from SurveyMonkey™ into SPSS for exploratory analyses and to EQS for 
confirmatory analyses.  
Sample 
Recruitment 
Participants for qualitative interviews were recruited in person, by the primary 
investigator, at the Infusion Therapy Department at a community hospital. Interested 
participants were presented with informed consent forms to engage in semi-structured 
interviews and to provide oral feedback on the initially developed set of items. Of the 
13 individuals offered to participate, 12 expressed interest. Qualitative interview 
participants were not compensated for their participation.  
During the online survey administration phase of the study, participants were 
recruited through Cint™. Eligibility criteria were added to ensure a census-balanced 
sample, with adequate representation across specific groups and geographic regions in 
the United States. Eligibility quotas were as follows: only patients with a history of 
cancer (100%), males (n = 233), females (n = 242), ages 18-22 (n = 43), ages 23-35 (n 
= 114), ages 36-55 (n = 185), ages 56-80 (n = 133), Midwest (n = 109), Northeast (n = 
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90), South (n = 171), and West (n = 105). All recruitment and human subjects 
procedures were approved by the [masked for anonymous review] and [masked for 
anonymous review] institutional review boards. 
Qualitative Interview Sample 
 Twelve, one-on-one, qualitative interviews were conducted by a clinical 
psychology doctoral student. The average age of the participants was 65.5 (SD = 10.9) 
and all participants had a present cancer diagnosis. Seven of the participants identified 
as female and five identified as male. All 12 participants identified as White.  
Measures 
Measures Used 
Cantril Self-Anchoring Striving Scale. The Cantril Self-Anchoring Striving Scale [43] 
was used to determine evaluative well-being outcomes. Individuals were asked to rate 
their current and future lives on a ladder scale from 0 to 10, in which 0 represented the 
worst possible life and 10 represented the best possible life. The first question aims to 
capture present subjective well-being: “Please imagine a ladder with steps numbered 
from 0 at the bottom, to 10 at the top. The top of the ladder represents the best possible 
life for you, and the bottom of the ladder represents the worst possible life for you. On 
which step of the ladder would you say you personally feel you stand at this time?” 
The second question aims to capture future subjective well-being: “On which step do 
you think you will stand about five years from now?” Individuals who rated their 
present lives a 7 or higher and their future lives an 8 or higher were classified as 
“thriving”. Individuals who rated their current lives a 4 or lower and their future lives 
a 4 or lower were classified as “suffering”. Individuals who met neither of these 
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criteria were classified as “struggling” (e.g., rated their current lives as 5 and future 
lives as 6). 
Measures Developed 
Stage of Change for Psychosocial Care. Participants were assigned to a Stage of 
Change based on their answers to a short series of questions. They were assigned to 
the Precontemplation stage if they indicated that they were not considering 
psychosocial care and did not intend to engage in it for the next 6 months; to 
Contemplation if they intended to seek psychosocial care within the next 6 months; 
and to Preparation if they intended to seek psychosocial care within the next 30 days. 
Participants were assigned to the Action stage if they were receiving psychosocial care 
and had been for less than 6 months, and Maintenance if they had been receiving 
psychosocial care for 6 months or more.  
Decisional Balance for Psychosocial Care. Thirteen items represented the Cons and 
eight items reflected the Pros. Respondents indicated how important each item was in 
their decisions of whether to accept psychosocial care, on a 5-point Likert scale, 
ranging from 1 = ‘Not Important At All’ to 5 = ‘Extremely Important’.  
Self-efficacy. Nine items assessed Self-efficacy. Items evaluated participants’ 
confidence in their ability to engage in psychosocial care across a variety of 
challenging situations (e.g., feeling fatigued after chemotherapy). Participants 
indicated their confidence levels on a 5-point Likert scale, ranging from 1 = “Not At 
All Confident” to 5 = “Extremely Confident”. 
Data Analysis 
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Data were examined for violations of normality before exploratory and 
confirmatory analysis. A random half of the sample was used for the exploratory 
phase using principal components analysis (PCA) with varimax rotation on item 
correlation matrixes. PCAs determined the number of components and reduced scales 
to a smaller set of items. The number of components retained was based on the 
minimum average partial procedure (MAP) and parallel analysis [44, 45]. Item 
selection was an iterative process that involved removing items for quantitative 
reasons (loadings <.40, or > .90 and correlations >.70 with other items, or high 
loadings [>.40] on multiple factors) and qualitative breadth of construct (to avoid 
redundancy and maintain conceptual breadth). The overall Cronbach alpha was 
examined to determine scale internal consistency.      
 The second half of the sample (n = 238) was used for confirmatory factor 
analysis (CFA). CFAs were used to evaluate the degree to which an independent 
portion of the data fit the model created by iterative PCAs. Model fit and factor 
loadings were evaluated. Final item selection was determined on the basis of item 
clarity, lack of redundancy, and conceptual breadth. Finally, Cronbach alphas and rho 
coefficients were examined to determine scale internal consistency. In the final phase, 
external validation analyses were conducted with the full sample (N = 475). First, the 
relationship between TTM constructs and Stages of Change was evaluated and 
compared to patterns seen in other areas of behavior change (Figures 1-3). Raw TTM 
construct scores (see Table 4) were translated to T-scores and weighted by group size 
to eliminate bias created by uneven Stage groups.     
 A chi-square test evaluated the association between participants’ mental health 
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treatment status (in treatment versus not in treatment) and Stage of Change for 
Psychosocial Care. ANOVA also evaluated the relationship between Self-Efficacy and 
Stage of Change. Next, MANOVA evaluated relationships between Decisional 
Balance and Stage of Change. ANOVA determined whether individuals in the 
Action/Maintenance stages of change showed different levels of well-being than those 
in pre-Action stages. Then, regression analyses evaluated relationships between TTM 
constructs and subjective well-being. Finally, relationships between constructs were 
evaluated for consistency with patterns seen for other behaviors (e.g., physical 
activity, cigarette smoking).  
RESULTS 
Survey Sample 
Cint ™ recruited 466 eligible adults to participate in the online survey portion 
of the study (sample demographics are summarized in Table 1). The sample was 
primarily female (54.6%, n = 255), and ages ranged from 18 to 78 (M = 47.89, SD = 
14.77). The majority (79%) of the sample was White (n = 368), 6.9% (n = 32) was 
multiracial or multiethnic, 4.9% (n = 23) was Hispanic/Latino, 4.1% (n = 19) was 
Black, 1.9% (n = 9) was Asian, 1.9% (n = 9) was American Indian/Native American, 
and 0.9% classified themselves as not fitting any of the aforementioned racial 
categories (n = 4). The majority of the sample (47.8%, n = 223) was in 
Precontemplation. Approximately one-fifth (22.1%, n = 103) were in Contemplation, 
8.1% (n = 38) were in Preparation, 8.6% (n = 40) were in Action), and 13.5% (n = 63) 
in Maintenance. 
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In addition to sociodemographic information, self-reported medical 
information was collected. The most common cancer diagnoses were: breast (16.8%), 
prostate (7%), cervical (5.1%), thyroid (4.9%), and skin-basal squamous cell (4.9%). 
Further, 23.4% of the sample reported multiple cancer diagnoses, as a result of 
metastasis. Given that 57 different cancer diagnoses were reported, variables were 
recoded such that diagnoses were organized according to organ system/site (e.g., 
gastrointestinal, gynecologic, skin), as presented by the National Cancer Institute 
(2016). Additional information regarding the sample’s cancer diagnoses and treatment 
may be found in Table 2. 
Stages of Change 
Descriptive Results 
 A series of chi-square tests of independence revealed relationships between 
Stage of Change and demographic variables. A chi-square test did not support an 
association between gender and stage, χ2 (4, n = 461) = 7.64, p = .12, phi = .12 or 
between race and stage, χ2 (4, n = 461) = 7.36, p = .12, phi = .13. However, a chi-
square test revealed an association between identifying as Hispanic/Latino and being 
in a pre-Action stage, χ2 (4, n = 460) = 31.37, p < .001, phi = .26. Additionally, chi-
square tests revealed no association between stage and level of education [χ2 (4, n = 
461) = 3.47, p = .48, phi = .09].  After variables were recoded to represent cancer site 
(e.g., GI, gynecologic, skin), as outlined by the NIH (2016), there was no association 
between stage and cancer site [χ2 (60, n = 467) = 48.75, p = .85, phi = .32]. Finally, the 
pattern of well-being, across the stages, differed for the three subjective present well-
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being categories (thriving, 50.8%; struggling, 39.7%; suffering, 9.5%), χ2 (8, n = 461) 
= 28.4, p < .001, phi = .25.                         
External Validity of Stage of Change Action Criterion 
 To test the validity of the Stage of Change measure, differences in subjective 
well-being scores [42] among individuals in pre-Action versus Action/Maintenance 
Stages of Change were evaluated using ANOVA. A significant difference was 
observed in present well-being scores between those in pre-Action stages versus 
Action/Maintenance (F (1, 1008) = 4.89, p = .03, h2 = .01). Individuals in the pre-
Action stages (M = 6.34, SD = 2.32) reported significantly greater levels of subjective 
well-being than individuals in Action or Maintenance (M = 6.01, SD = 2.37). 
However, an ANOVA revealed that between-stage differences in future subjective 
well-being scores were not significantly different for those in the pre-Action and 
Action stages, (F(1, 1010) = .02, p = .88). Finally, a chi-square test revealed an 
association between subjective well-being category (thriving, struggling, suffering) 
and Stage of Change, χ2 (8, n = 461) = 28.40, p < .001, phi = < .001.  
Decisional Balance and Self-efficacy 
Exploratory Analyses 
 Exploratory procedures included PCA with varimax rotations. Sample size (n 
= 237) was adequate based on existing literature [46]. Decisions regarding retention of 
components were based on parallel analysis and minimum average partial procedures 
(MAP), both of which have been found to be accurate methods. Exploratory analyses 
were used to determine the number of components, the correlation between 
components, and the loadings of items on these components. Items with poor (<.40) 
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and/or complex loadings (>.40) on more than one factor were removed. In later steps, 
items with content overlap were removed.  
Decisional Balance 
 Twenty-one decisional balance items were included in the initial exploratory 
factor analysis. PCA with varimax rotation on the 21 x 21 matrix of item 
intercorrelations was conducted to determine the factor structure of the decisional 
balance measure. A total of 6 iterative PCAs were conducted, which reduced the 
original pool of 21 items to 16, with 8 items reflecting Pros and 8 items reflecting 
Cons. Parallel analysis indicated a two-factor solution. Examination of the item 
content revealed that one factor (8 items) clearly reflected the pros of utilizing 
psychosocial services and one factor (8 items) clearly reflected the cons of utilizing 
psychosocial services. All item loadings were above 0.522. Internal consistency was 
excellent for the Pros scale (α = 0.933) and good for the Cons scale (α = 0.809). 
Together, the two factors accounted for 56.41% of the total variance (35.66% for Pros 
and 20.74% for Cons). The retained items can be viewed in Figure 4.  
Decisional Balance – Short Form (DB-SF) 
 For development of the DB-SF, the 16 decisional balance items from the full 
measure were included in the initial exploratory factor analysis. PCA with varimax 
rotation on the 16 x 16 matrix of item intercorrelations was conducted to determine the 
factor structure of the measure. A total of 3 iterative PCAs was conducted, which 
reduced the original pool of 16 items to 8, with 4 items reflecting Pros and 4 items 
reflecting Cons. Parallel analysis indicated a two-factor solution, which was retained. 
Examination of item content revealed that one factor (4 items) clearly reflected the 
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pros of utilizing psychosocial services and one factor (4 items) reflected the cons of 
utilizing psychosocial services. All item loadings were above .641. Internal 
consistency was good for the Pros scale (α = .874) and acceptable for the Cons scale 
(α = .716). Together, the two factors accounted for 61.94% of the total variance 
(38.29% for Pros and 23.66% for Cons). The final set of retained items can be viewed 
in Figure 5.  
Self-efficacy 
 All nine Self-efficacy items were included in the initial exploratory factor 
analysis. PCA with varimax rotation on the 9 x 9 matrix of items intercorrelations was 
conducted to determine the factor structure of the measure. Four PCAs were 
conducted, which reduced the initial pool of nine items to six. MAP and parallel 
analysis supported a single component solution. However, PCA supported a two-
component solution. Therefore, the two-factor solution was retained. Examination of 
the item content revealed that one factor (3 items) clearly reflected the physical 
challenges to utilizing psychosocial services (α = .904) and one factor (3 items) clearly 
reflected the social and emotional challenges utilizing psychosocial services (α = 
.757). Item loadings ranged from .667 to .919. The resulting scale had good internal 
consistency (α = .826) and accounted for 75.46% of the total variance. The final set of 
retained items can be found in Figure 6.  
Confirmatory Analyses 
 Confirmatory factor analyses were conducted with the structural equation 
modeling software, EQS, using the remaining subsample (n = 238) [46]. Maximum 
likelihood estimation methods were used for fit indices since item data was ordinal 
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[46]. The fit indices calculated were the Satorra-Bentler scaled chi-square, the 
comparative fit index (CFI), and the absolute standardized residual statistic (AASR). 
CFI values of 0.90 and above are considered to indicate good fit [47]. RMSEA values 
between .05 and .08 suggest reasonable error of approximation and values >.10 
indicate poor fit [48].                      
Decisional Balance 
 The following measurement models were compared for the 16-item Decisional 
Balance measure: (1) a null model that supported 16 independent variables and no 
latent factors; (2) a single-factor model; (3) a two-factor uncorrelated model; and (4) a 
two-factor correlated model. Fit indices for each model are summarized in Table 3. 
The two-factor correlated model showed the best fit to the data. Factor loadings 
ranged from .464 to .878. Fit indices suggested good model fit, χ2(103) = 349.563, p < 
.001, CFI = .928, RMSEA = .075. The correlation between the two scales was r = .147 
and rho coefficients were excellent for Pros (ρ = .932) and good for Cons (ρ = .816). 
The final items and their loadings in the confirmatory subsample are presented in 
Figure 5.  
Decisional Balance – Short Form (DB-SF) 
The following measurement models were compared for the 8-item Decisional 
Balance (SF) measure: (1) a null model that supported 8 independent variables and no 
latent factors; (2) a one-factor model; (3) a two-factor uncorrelated model; and (4) a 
two-factor correlated model. Fit indices for each model are summarized in Table 3. 
The two-factor correlated model showed the best fit to the data. Factor 
loadings ranged from .641 to .893. Fit indices suggested good model fit, χ2(19) = 
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68.56, p < .001, CFI = .962, RMSEA = .078. The correlation between the two scales 
was r = .14 and rho coefficients were good for Pros (ρ = .872) and acceptable for Cons 
(ρ = .755).  The final items and their loadings in the confirmatory subsample are 
presented in Figure 5. 
Self-Efficacy 
The following measurement models were compared for the Self-efficacy scale: 
(1) a null model that supported six independent variables and no latent factors; (2) a 
single factor model; (3) an uncorrelated 2-factor model; and (4) a correlated 2-factor 
model. Fit indices for each model are summarized in Table 3. 
The correlated two-factor model had the best fit. Factor loadings ranged from 
.572 to .923 and there was excellent model fit, χ 2(8) = 23.72, p = .003, CFI = .989, 
RMSEA = .067. The correlation between the two factors was r = .575. Internal 
consistency was good (“social/emotional” α = .757; “physical” α = .904; total α = 
.851). Final items and loadings are presented in Figure 2. 
External Validation 
Decisional Balance by Stages of Change 
 Multivariate analysis of variance (MANOVA) indicated that individuals at 
different Stages of Change differed significantly on Decisional Balance constructs for 
the full (F(8,878) = 12.04, p < .001, Wilks’ l = .812; η2 = .10) and short-form (SF) 
(F(8,894) = 12.72, p < .001, Wilks’ l = .806; η 2 = .10) measures. Follow-up 
ANOVAs indicated significant between-stage differences on the Pros for the full 
measure (F(4,449) = 18.39, p < .001, η2 = .14) and for SF; F(4,454) = 19.64, p < .001, 
η2 = .15. Post hoc analyses indicated that the Pros were significantly higher for 
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individuals in the Action and Maintenance stages than for those in the 
Precontemplation stage.        
 Follow-up ANOVAs indicated significant between-stage differences on the 
Cons for full measure (F(4,452) = 5.48, p < .001, η2 = .05) and SF (F(4,456) = 6.7, p < 
.001, η2 = .06. Post hoc analyses indicated that the Cons were significantly lower for 
individuals in the Action and Maintenance stages than for those in the 
Precontemplation stage. Weighted T scores of Pros and Cons at each Stage of Change 
are presented in Figures 1 and 2. 
Self-efficacy by Stages of Change 
 Multivariate analysis of variance (MANOVA) indicated that Self-Efficacy was 
significantly different across the Stages of Change, (F(8,906) = 6.18, p < .001, Wilks’ 
l = .899; η2 = .05). Follow-up ANOVAs indicated significant between-stage 
differences on the Physical (F(4,456) = 4.31, p < .01, η2 = .04) and Social/Emotional 
(F(4,459) = 10.49, p < .001, η2 = .08) factors. Follow-up comparisons showed that 
Self-efficacy of individuals in the Precontemplation and Preparation stages was 
substantially lower than that of those in the Action and Maintenance stages. Weighted 
T- scores of Self-efficacy at each Stage of Change are presented in Figure 4. 
External Validation 
A series of linear regressions were conducted to evaluate relationships between 
subjective well-being (present and future) scores and TTM constructs (Pros, Cons, 
Physical Self-Efficacy, and Social/Emotional Self-Efficacy). Greater subjective 
present well-being was associated with greater Physical Self-Efficacy (β = .06, p < 
.05). Additionally, greater subjective future well-being scores were associated with 
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fewer perceived Cons (β = -.11, p <.001). However, no significant relationships 
between present well-being and Social/Emotional Self-Efficacy (β = .01, p = .75), 
Cons (β = -.01, p = .66), and Pros (β  = .05, p = .15) were observed. Finally, results 
revealed no significant relationships between future well-being and Pros (β = .03, p = 
.31), Physical Self-Efficacy (β = .05, p = .14), and Social/Emotional Self-Efficacy (β = 
.05, p = .09). 
DISCUSSION 
Results supported the validity of the Stages of Change measure and its 
relationship with key TTM constructs. Measure development results demonstrated 
good construct validity for Decisional Balance and Self-Efficacy in a national sample 
of adults diagnosed with cancer. Additionally, both scales demonstrated external 
validity in their relationship with Stages of Change. Consequently, the present study 
provides evidence of validity for measures that may be used to design and manage 
interventions in cancer treatment settings. 
Stages of Change for Psychosocial Care 
 Findings supported the validity of Stages of Change for psychosocial care. 
First, the significant association between subjective well-being category (thriving, 
struggling, suffering) and Stage of Change for Psychosocial Care was consistent with 
previous literature. Based on these, interventions and treatment team members should 
consider individuals’ subjective well-being in encouraging psychosocial care. Second, 
the significant difference in subjective present well-being between those in the pre-
Action (i.e., Precontemplation, Contemplation, Preparation) and Action stages 
(Action, Maintenance) was also consistent with previous literature. Surprisingly, 
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however, no significant differences were observed between stage groups for subjective 
future well-being or well-being category. One interpretation for this finding may be 
that uneven membership in well-being categories (50.8% thriving, 39.7% struggling, 
9.5% suffering) limited our ability to find differences between small groups. Notably, 
the weekly U.S. Life Evaluation of 3,500 randomly selected adults revealed that 
54.9% were thriving, 42.1% were struggling, and 3% were suffering [49]. This 
distribution across wellbeing categories in a national sample of well adults was 
remarkably similar to the distribution found in this sample of cancer patients. This 
suggests that even when faced with a life-threatening illness, subjective life 
evaluations remain comparable. Thus, overall findings support the future use of Stage 
of Change for psychosocial care. 
Decisional Balance 
 The present study supported a two-factor correlated model for the Decisional 
Balance scale, with one factor reflecting the Pros and the other the Cons of engaging 
in psychosocial care. This was consistent with previous studies, in which a two-factor 
Decisional Balance model was observed across health risk behaviors [48]. Further, the 
present findings converged with existing literature, with regard to the Cons 
outweighing the Pros in Precontemplation and an increase in Pros with progress to the 
Action and Maintenance Stages of Change [38]. Thus, Decisional Balance emerged as 
a critical construct in readiness to engage in psychosocial care. 
 In comparing Decisional Balance for psychosocial care with other problem 
areas, one difference emerged. There was an increase in perceived Cons between the 
Precontemplation and Contemplation stage groups, as well as between the Preparation 
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and Action stage groups. One interpretation of this trend may be that ambivalence 
occurs during Preparation and Action stages, as opposed to Precontemplation. 
Nonetheless, the general trend was similar to the trend observed in other areas of 
behavior change, such that the Cons were more salient than Pros in Precontemplation, 
whereas Pros were more salient than Cons in Maintenance. Although replication and 
longitudinal follow-up are warranted, the present study suggests that tailored 
interventions should focus on feedback to address Cons during the Contemplation and 
Action stages, in order to maintain forward stage progress. For example, clinicians 
could address patient concerns regarding continuing psychosocial care throughout the 
Action stage. Given the common patient concern regarding psychologists sharing 
treatment information with the rest of the treatment team, best practices should be 
used in communicating psychosocial treatment information [49].  
 Findings were mixed with regard to the relationship between subjective well-
being and perceived Pros and Cons. First, there was no relationship between Pros and 
present or future subjective well-being. Second, no relationship was observed between 
Cons and present subjective well-being. However, individuals with greater future 
subjective well-being perceived fewer Cons of engaging in psychosocial care. Thus, 
addressing perceived Cons of psychosocial care may be helpful in modifying 
subjective future well-being. However, given these cross-sectional findings, those with 
greater future well-being scores may be perceiving fewer cons of psychosocial care. 
Self-Efficacy 
 This research supported a two-factor correlated model for Self-Efficacy. This 
finding diverged from some previous research on Self-Efficacy across other health 
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behavior change, in which a single-factor scale was supported. Nonetheless, Self-
Efficacy was greater for individuals in the Action and Maintenance stages, compared 
with those in the pre-Action stages – a finding observed in other areas of behavior 
change. The present finding is comparable to situational temptations subscales 
(Positive Social, Negative Affect, and Habit Strength) observed for smoking [40] and 
high-fat diet [50]. One implication of the two-factor Self-Efficacy model is the strong 
physical component to having cancer. As such, experiencing pain, physical 
discomfort, and fatigue collectively reflect a unique component to Self-Efficacy. This 
finding sheds light on the low engagement rates among cancer patients, as they face 
unique challenges due to physical demands of their diagnoses and treatments. 
Accordingly, tailored interventions and treatment teams may consider and incorporate 
physical aspects of patients’ cancer experiences in psychosocial care engagement. 
Notably, these findings support the use of integrative care approaches to cancer 
treatment – ones that incorporate physical therapy, rehabilitation, nutrition services, 
and mental health care [53-56].  
Validation analyses further supported the developed Self-Efficacy measure. 
Self-Efficacy was significantly different across Stages of Change, demonstrating its 
utility in facilitating readiness to change. More importantly, Self-Efficacy was 
significantly lower in the pre-Action stages, compared with the Action stages, 
validating its role in acceptance of psychosocial care. The relationship between Self-
Efficacy and present well-being provided further external validation for this measure, 
as those with greater confidence for engaging in psychosocial care across a range of 
challenging situations had greater subjective present well-being. These results indicate 
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that Self-Efficacy may be an essential component for feedback in an intervention or 
feedback session aimed at reducing reluctance or ambivalence to meet with a mental 
health provide or to attend a support group. 
Limitations and Future Directions 
 This study has several limitations. First, 47.8% and 22.1% of the survey 
sample was in Precontemplation and Contemplation, respectively. Although sample 
sizes were adequate for internal validation analyses – and scores were weighted by 
sample size for external validation analyses, it is likely that the smaller Preparation 
(8.1%), Action (8.6%), and Maintenance (13.5%) sample sizes limited the power for 
comparisons with other stage groups. Future research evaluating findings in larger 
samples including Preparation, Action, and Maintenance stages is warranted. Second, 
findings are based on cross-sectional comparisons of individuals in each Stage of 
Change. Although cross-sectional findings provide insight into factors that drive 
change, they do not warrant longitudinal implications. Third, findings are based on a 
sample that is mainly White and non-Hispanic. Furthermore, the qualitative interview 
sample (n = 12) consisted exclusively of White participants. Given the differences in 
cancer outcomes and mental health stigma among non-White populations [56], 
additional research examining the validity of these measures in non-White populations 
is warranted. Additionally, repeating the qualitative interviews with a more diverse 
sample, from several different hospitals would be useful for further validation. Fourth, 
the survey sample consisted of individuals who were enrolled in a health panel and 
therefore had interest in online survey research participation, potentially introducing 
sample bias. Finally, although the sample was diverse with regard to cancer site and 
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cancer treatment type, cancer staging data was not available. Given strong cross- 
cancer stage differences, with regard to physical and psychological functioning (e.g., 
lower physical functioning in Stage IV cancer, compared with Stage I), future research 
that investigates cancer staging data is recommended. 
 Despite its limitations, the study has numerous strengths and can inform future 
investigations. Notably, this study developed and validated three key TTM constructs 
– Stages of Change, Decisional Balance, and Self-Efficacy for Psychosocial Care in a 
large, national sample of cancer patients. These measures can be used in various ways. 
First, researchers may evaluate the impact of readiness to engage in psychosocial care 
on both, psychological and physiological treatment outcomes, including cancer 
survival rates. Second, cancer treatment teams may use this data to inform intervention 
strategies. For instance, clinicians may use psychoeducation and motivational 
interviewing in order to address ambivalence and thereby foster forward stage 
progress. Finally, the study findings support patient distress screenings in order to 
increase psychosocial care referrals and consequently, increase engagement in care. In 
sum, these findings may be used in intervention development and implementation in 
order to design treatments that are tailored to individuals’ readiness to accept 
psychosocial care as a component of their cancer treatment plans. 
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Table 1. 
Demographic Characteristics. 
Variable Participants 
Sex % (n) 
     Female 54.6% (n=255) 
     Male 44.3% (n=207) 
     Other 1.1% (n=5) 
Race/Ethnicity 
     Native American 1.9% (n=9) 
     Asian/Pacific Islander 1.9% (n=9) 
     Black 4.1% (n=19) 
     Hispanic/Latino 4.9% (n=23) 
     Middle Eastern 0.4% (n=2) 
     Multiracial 6.9% (n=32) 
     Other 0.9% (n=4) 
     White 79% (n=368) 
Marital Status 
      Married 54.3% (n=253) 
     Divorced 12.7% (n=59) 
     Living with partner 11.2% (n=52) 
     Not married 17% (n=79) 
     Separated 1.3% (n=6) 
     Widowed 3.6% (n=17) 
Education 
      <High school 2.5% (n=12) 
     High school diploma 14.8% (n=69) 
     Some college 19.3% (n=90) 
     Trade/vocational school 6.9% (n=32) 
     Associate degree 12% (n=56) 
     Bachelor's degree 25.7% (n=120) 
     Master's degree 12.6% (n=59) 
     Professional/doctorate degree  6.2% (n=29) 
Stage of Change  
     Precontemplation 47.8% (n=223) 
     Contemplation 22.1% (n=103) 
     Preparation 8.1% (n=38) 
     Action 8.6% (n=40) 
     Maintenance 13.5% (n=63) 
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Table 2. 
Medical Characteristics. 
Variable Participants 
Cancer Site % (n) 
     Breast 16.8 (n=79) 
     Digestive/Gastrointestinal 8.7 (n=41) 
     Endocrine/Neuroendocrine 4.9 (n=23) 
     Eye 0.4 (n=2) 
     Genitourinary 12.4 (n=58) 
     Gynecologic 8.5 (n=40) 
     Head & Neck 3.4 (n=16) 
     Hematologic/Blood 6.6 (n=31) 
     Musculoskeletal 0.6 (n=3) 
     Neurologic 1.3 (n=6) 
     Respiratory/Thoracic 1.5 (n=7) 
     Skin 9 (n=42) 
     Unknown Primary 0.2 (n=1) 
     Metastasized 23.5 (n=110) 
     Other 1.7 (n=8) 
     Soft Tissue 0.4 (n=2) 
Treatment location 
      Homeopath 1.5% (n=7) 
     Major cancer center 19.4% (n=92) 
     Not receiving treatment 7.8% (n=37) 
     Outpatient office 33.5% (n=159) 
     General hospital 37.9% (n=180) 
     Community hospital 9.7% (n=46) 
     VA hospital 5.7% (n=27) 
Treatment type (not mutually exclusive) 
      Blood Product Donation  7.8% (n=37) 
     Chemotherapy 43.4% (n=206) 
     Homeopathy 4.4% (n=21) 
     Hyperthermia 4.4% (n=21) 
     Immunotherapy 6.1% (n=29) 
     Photodynamic therapy 1.3% (n=6) 
     Radiation 38.1% (n=181) 
     Stem Cell Transplant 2.7% (n=13) 
     Surgery 52.4% (n=249) 
     Targeted therapy 11.6% (n=55) 
  
Table 3. 
Fit Indices for Evaluated Decisional Balance and Self-Efficacy Confirmatory Models 
  χ 2 (df) CFI RMSEA (CI) 
Decisional Balance 
   Model 1: null model 3546.08 (120) -- -- 
Model 2: one-factor model 1126.87 (104)* .701 .152 (.144, .160) 
Model 3: uncorrelated two-factor model 356.74 (104)* .926 .076 (.067, .084) 
Model 4: correlated two-factor model 349.56 (103)* .928 .075 (.066, .084) 
Decisional Balance-Short Form    
Model 1: null model 1342.98 (28) -- -- 
Model 2: one-factor model 449.39 (20)* .673 .223 (.205, .240) 
Model 3: uncorrelated two-factor model 224.56 (20)* .891 .163 (.143, .311) 
Model 4: correlated two-factor model 68.56 (19)* .962 .078 (.058, .097) 
Self-Efficacy    
Model 1: null model 1400.959 (15) -- -- 
Model 2: one-factor model 239.147 (9)* .834 .242 (.215, .268) 
Model 3: uncorrelated two-factor model 146.612 (9)* .901 .187 (.16, .213) 
Model 4: correlated two-factor model 23.72 (8)** .989 .067 (.037, .099) 
 
Note. N = 238; χ 2 = chi square; df = degrees of freedom; CFI = comparative fit index; RMSEA = root mean square error of 
approximation; CI = confidence interval; *p < .001; **p < .01. 
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Table 4. 
Summary of Raw Scores on Pros, Cons, and Self-Efficacy by Stage 
 
  
Pros Cons Self-Efficacy 
Stage N Mean (SF) SD (SF) Mean (SF) SD (SF) Mean SD 
Precontemplation 219 24.2 (11.86) 7.57 (4.00) 20.79 (8.93) 5.97 (3.60) 17.08 5.54 
Contemplation 101 29.16 (14.51) 7.36 (3.80) 23.19 (10.75) 7.65 (4.21) 19.32 5.3 
Preparation 37 29.65 (14.66) 7.97 (4.28) 19.51 (8.70) 7.79 (4.33) 20.19 4.7 
Action 40 29.63 (14.95) 7.29 (3.56) 22.05 (9.87) 6.66 (3.76) 18.97 4.27 
Maintenance 60 31.87 (15.95) 7.42 (3.71) 18.37 (7.84) 8.03 (4.06) 20.61 4.75 
 
Note. Mean = average sum score; higher scores indicate more importance for Pros and Cons and more confidence for Self-Efficacy; 
SD = standard deviation; scores in parentheses indicate those from the Decisional Balance Short – Form (SF) measure
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Table 5. 
2 x 2 Contingency Table for Chi-Square Test Reporting the Association between 
Subjective Well-Being Category and Stage of Change 
 
 
Subjective Well-Being Category 
 
  Thriving 
Struggling
/Suffering 
Stage 
Pre-
Action 
81.2% 
(190) 
74.9% 
(170) 
  AM 
18.8% 
(44) 
25.1%  
(57) 
 
Note. Pre-Action = Precontemplation, Contemplation, or Preparation Stages; AM = 
Action or Maintenance Stages. 
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Figure 1. 
Stage of Change by Decisional Balance. 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance 
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Figure 2.  
Stage of Change by Decisional Balance – Short Form (SF). 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance 
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Figure 3. 
Stage of Change by Self-efficacy. 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance; “physical” represents the physical challenges to engaging in 
psychosocial care and “social/emotional” represents the social and emotional 
challenges to engaging in psychosocial care 
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Figure 4. 
Decisional Balance Structural Model (N=238) 
 
I could improve the quality of my 
life 
I could identify any problems 
that I am experiencing and set 
goals for addressing them 
I can talk to someone who can be 
helpful about the issues I am 
experiencing 
Having a therapist or counselor 
on my treatment team can 
improve my health 
Therapy can help me deal with 
issues related to my health 
It would be embarrassing if my friends or 
family found out that I am seeing a 
psychologist or counselor 
Seeing a therapist is unlikely to 
help me cope with my cancer 
diagnosis and treatment 
It is uncomfortable to talk about 
my problems with a stranger 
My cancer treatments can leave 
me too fatigued for 
psychotherapy 
Seeking help is a sign of 
weakness 
Pros 
α = 0.93 
Cons 
α = 0.81 
Psychosocial care can help me 
cope with stress related to my 
diagnosis and treatment 
Receiving psychosocial care may 
improve my cancer prognosis 
Psychosocial care can help me 
deal with interpersonal issues 
related to my diagnosis 
Time in psychotherapy can take 
away from the things I’d rather 
do 
I would be uncomfortable if my personal 
information was shared with other 
members of my treatment team  
I feel that I can cope with the 
stress related to cancer without 
therapy 
.71 
.66 
.78 
.83 
.86 
.89 
.71 
.86 
.56 
.46 
.67 
.52 
.68 
.75 
.65 
.46 
r = .15 
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Figure 5. 
Decisional Balance (Short Form) Structural Model (N=238) 
 
I could improve the quality of 
my life 
It would be embarrassing if 
my friends or family found out 
that I am seeing a psychologist 
or counselor 
Seeking help is a sign of 
weakness 
Pros 
α = .87 
Cons 
α = .75 
Psychosocial care can help me 
cope with stress related to my 
diagnosis and treatment 
Receiving psychosocial care 
may improve my cancer 
prognosis 
Psychosocial care can help me 
deal with interpersonal issues 
related to my diagnosis 
Time in psychotherapy can 
take away from the things I’d 
rather do 
I would be uncomfortable if 
my personal information was 
shared with other member of 
my treatment team  
.67 
.89 
.72 
.87 
.55 
.69 
.79 
.60 
r =.14 
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Figure 6. 
Self-Efficacy Structural Model 
 
 
 
Family members or 
friends do not see 
the value in 
psychosocial care 
You have to 
follow-up in 
therapy or support 
group meetings 
You are in physical 
discomfort 
You are in pain 
You are feeling 
fatigued 
 
Social 
α = 0.76 
 
 
Physical 
α = 0.90 
 
You need to share 
feelings about your 
diagnosis and 
treatment .88 
.92 
.89 
.86 
.84 
.67 
How confident are you that you can 
engage in psychosocial are when…? 
r = .58 
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Abstract 
BACKGROUND. Cancer patients frequently experience considerable distress during 
diagnosis and treatment. The aims of this study were to describe the development and 
utilization of a behavioral health program for cancer patients, at a small community 
hospital, as well as to provide preliminary results on program efficacy. METHODS. 
This program was developed collaboratively by individuals from a university-based 
clinical psychology doctoral program and a community hospital. The behavioral health 
program was comprised of a licensed, PhD-level clinical psychologist and seven 
clinical psychology doctoral students. Patients were typically referred by their 
oncologists or nurses. Distress, depression, and anxiety were evaluated for a small 
subsample of participants. RESULTS. From the time the program was initiated, 238 
patients between ages 18 and 95 (M = 66.4) were evaluated over a three-year period. 
The majority of patients (77.8%) were offered psychosocial care. Although 49.8% 
declined treatment, 23.6% engaged in one session and 26.6% engaged in two or more. 
Patients who were referred through the STAR Program® were more likely to engage 
in psychosocial care than those who found out about behavioral health in other ways. 
CONCLUSIONS. First, distress tracking may be improved if nurses, oncologists, and 
behavioral health providers administer measures. Second, partnerships between 
clinical psychology doctoral programs and hospitals may be mutually beneficial. 
Third, hospitals offering cancer treatment may benefit from obtaining STAR® 
certification, in order to generate referrals for comprehensive cancer care. These 
efforts can serve as a model for other hospitals seeking to integrate behavioral health 
into routine cancer treatment.  
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Given improvements in early detection, diagnosis, and treatment, individuals 
with cancer are living longer. Often times, their diagnosis may be managed as a 
chronic illness (McCorkle et al., 2011). However, although providers may be 
prolonging lives, insufficient attention is being paid to quality of lives. In 2005, The 
Institute of Medicine (IOM)’s report, From Cancer Patient to Cancer Survivor: Lost 
in Transition, discussed a cancer care continuum, ranging from diagnosis and 
treatment, to survivorship. This report, along with changing U.S. health care delivery 
systems, underscores the importance of better integrated models of care. Such models 
include partnerships between oncologists and providers from other disciplines, 
including psychology, social work, and primary care. More importantly, given that 
severe and acute distress often begins at the time of cancer diagnosis, these 
partnerships should last throughout the cancer care continuum in order provide care 
that can improve clinical outcomes and enhance quality of life simultaneously 
(Andersen et al., 2009). Notably, oncologists and nurses are encouraged to have 
discussions with patients regarding the psychosocial effects of cancer, in part to 
connect patients to psychosocial services (Forsythe et al., 2013). To illustrate the 
distinct and unique role of such partnerships, Silver & Baima (2013) defined cancer 
“pre-habilitation” as a process, on a continuum of care, that occurs between the time 
of cancer diagnosis and the beginning of acute treatment, including physical and 
psychological assessments.  
The changing U.S. healthcare landscape places an urgent emphasis on 
improving the quality of patient care and on reducing overall costs, particularly within 
hospitals. A recent systematic review of 78 studies revealed that collaborative care 
   
 50 
models improved mental and physical outcomes for individuals with mental disorders 
across a wide variety of care settings, supporting care integration (Woltmann et al., 
2012). Similarly, a review of psychosocial interventions for cancer revealed that the 
biomedical model of disease does not take into account all of the complex factors 
involved in cancer, underscoring the need for a broader, more integrative framework 
for cancer care that integrates psychosocial factors (Shapiro et al., 2001). Notably, 
recent models have converged on the use of multimodal, multidisciplinary 
interventions to decrease cancer-related morbidity, increase survival rates, improve 
physical and psychological health outcomes, decrease hospital readmissions, and 
reduce healthcare costs (e.g., Mehnert & Koch, 2008; Purushotham, et al., 2013; 
Stanton, Luecken, MacKinnon, & Thompson, 2013). Findings from a recent study of 
1,083 women with breast cancer generated recommendations for patient education, 
screening for psychosocial distress, and tailoring psychosocial interventions for older 
women (Mehnert & Koch, 2008). Unfortunately, despite evidence that up to 35% of 
patients with cancer experience significant distress, only five percent obtain 
psychological help (National Comprehensive Cancer Network, 2016). Access to 
effective psychosocial care is often limited by lack of systematic approaches to 
assessment, scarcity of psychosocial services, and patient reluctance to accept 
treatment, mainly due to perceived stigma (Zabora et al., 2001). Nonetheless, the 
literature has evolved to encourage broader and better integrated models of care, rather 
than treating cancer from a solely biomedical model. 
Given the limitations of the biomedical model, research supports that 
multidisciplinary collaborative care teams are more likely to deliver favorable cancer 
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treatment outcomes. Notably, a randomized trial of psychosocial support groups 
revealed that the use of multidisciplinary collaborations enhanced enrollment rates in 
psychosocial interventions (Goodwin et al., 2000). Such improvements have often 
been attributed to having cancer treatment providers (e.g., oncologists, nurses) 
introduce and recommend behavioral health treatment, thereby increasing 
engagement. However, due to insufficient behavioral health providers in oncology 
settings, nurses and oncologists are often expected to screen for patient distress and to 
provide therapeutic services (Fallowfield, Ratcliffe, Jenkins, & Saul, 2001). 
Problematically, Sollner et al. (2001) found that oncologist recommendations for 
counseling did not correlate with patient distress, implying that oncologists’ ability to 
identify patients in distress is generally insufficient. Additionally, a recent study of 
448 oncologists revealed that 38% of their patients experienced psychological distress 
requiring intervention, but only half of those oncologists had any mental health 
services affiliated with their practices. Additionally, only 47% made a referral for 
psychosocial services (Muriel et al., 2015). These data suggests that multidisciplinary 
teams, representing professionals with different areas of expertise (e.g., nursing, 
oncology, psychology) may be more likely to deliver effective care and to enhance 
treatment outcomes. However, providing psychosocial care to cancer patients comes 
with numerous barriers, including the need for systematic approach to identifying 
patients with unmet psychosocial needs, as well as provider, patient, financial, and 
organizational challenges (Fann & Sharpe, 2012).  
Survivorship Training and Rehabilitation (STAR) Program ®  
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 STAR® is a free access, evidence-based program that provides nutrition 
counseling, physical rehabilitation, caregiver support, monitoring tools, and behavioral 
health services for cancer patients (Kirschner et al., 2013; Silver et al., 2013; Silver & 
Baima, 2013; Silver, Baima, Mayer, 2013; Silver & Gilchrist, 2011; Silver & Mayer, 
2007; Silver, 2007; 2010; 2011; 2013; 2014; 2014; Silver et al., 2015a,b). The 
program aims to address a wide array of cancer-related physical and psychological 
impairments, all of which potentially interfere with treatment recommendations and 
coping. As of November 2016, 549 hospitals or cancer centers possess STAR® 
certification, nationwide. The main benefits of possessing STAR Program® 
certification are: 1) improved patient outcomes, by way of intervening on quality of 
life with evidence-based clinical protocols; 2) increased access to care; 3) improved 
clinician knowledge, while improving delivery of care; 4) increased patient referrals, 
which often generate a self-sustaining service and decrease the economic impact of 
cancer on patients, caregivers, and the healthcare system; and 5) enhanced community 
education by supporting local and regional awareness initiatives (STAR®, 2015). 
Purpose of Current Study 
  As the literature supporting the efficacy of biobehavioral cancer care 
continues to grow (e.g., Lutgendorf & Anderson, 2015) a dearth of reporting on 
psychosocial cancer care programs prevails. Notably, a recent study revealed the 
scarcity of studies on the intersection of cancer and mental health and suggested the 
need to bridge the gap between these two disciplines, in order to prevent and treat 
mental health problems in cancer patients (Purushotham et al., 2013). Collectively, 
research has identified: 1) a gap between the need for and delivery of services; 2) that 
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dual screening for psychological distress and physical impairment is critical for 
optimal outcomes; and 3) integrated rehabilitative services are cost-effective. 
Accordingly, the current study describes the development, preliminary evaluation, and 
utilization of a behavioral health program integrated into routine cancer care at a 
STAR Program® - certified hospital. 
METHODS 
Setting and Program Description 
 The study took place at an independent, non-profit acute care hospital serving 
[area masked for anonymous review]. Prior to the beginning of data collection, the 
program was collaboratively designed by hospital administrators, clinicians, and staff, 
as well as faculty and two graduate students from a clinical psychology doctoral 
program at a northeastern, public research university. The goals of this program were 
to: 1) increase access to behavioral health services to cancer patients; and 2) provide 
students with a one-year, formally supervised clinical training experience.   
 In August 2013, one emeritus faculty member [masked for anonymous review] 
and two doctoral Psychology students [masked for anonymous review] were recruited 
to implement behavioral health services for patients receiving cancer treatment on an 
outpatient basis. The faculty member served as the clinical supervisor for the two 
students and provided weekly group and individual supervision for all cases. All three 
providers documented clinical encounters. Upon completion of this training 
experience (August 2014), three new doctoral Psychology students replaced the first 
two students, although one of the students [masked for anonymous review] remained 
on the team as a peer supervisor from 2014 to 2015.    
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 During Year 2 (2014-2015) of this program, [masked for anonymous review] 
launched a weekly, three-hour didactic seminar co-led by a Clinical Assistant 
Professor of Psychiatry in the Behavioral Medicine Track at [masked for anonymous 
review] and the peer supervisor [masked for anonymous review] to supplement the 
training experience, formally named the “Health Practicum”. The purpose of the 
didactic portion of this practicum was to: 1) provide additional supervision; 2) hold 
formal trainings on health psychology; and 3) discuss the application of Cognitive-
Behavioral Therapy (CBT) and Acceptance and Commitment Therapy to cancer 
patients and other clinical populations. Upon completion of this training experience in 
August 2015, two new doctoral students joined the behavioral health team at the 
hospital for Year 3 (2015-2016) of the program. This program continues to be 
available to all patients and caregivers at [masked for anonymous review] and the 
“Health Practicum” continues to run. 
All behavioral health providers completed the STAR Program® Certification 
course. The course is a 10-module training, based on recent evidence on best practices 
with regard to cancer treatment and rehabilitation. The modules covered a vast array 
of information, including an overview of cancer rehabilitation, an overview of cancer 
biology and available treatments, common impairments related to cancer, and best 
practices for selecting assessment tools. Upon completion of the course, participants 
took the STAR® Certification Test, an online examination in order to receive STAR® 
Clinician Certification.  
Data Collection 
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All procedures were in accordance with the Institutional Review Boards of 
[masked for anonymous review] and [masked for anonymous review]. The period of 
data collection was from the initiation of behavioral health services (August 2013) to 
June 30, 2016. Nursing staff administered the National Cancer Care Network (NCCN) 
distress thermometer (NCCN, 2016) to patients and compiled the documentation for 
behavioral health staff. The purpose of NCCN administration was to: 1) screen for 
distress; 2) provide preliminary data for behavioral health staff; and 3) prioritize 
patient assignments (i.e., in the event of understaffing, patients with a higher distress 
scores would be seen first).  
Measures 
Demographics. Patients who accepted psychosocial treatment provided their gender, 
age, race/ethnicity, marital status, and employment status during the intake. A 
retrospective chart review was conducted to obtain this information from individuals 
who only attended support groups or those who were referred, but declined 
psychosocial care. For all patients, medical information was obtained, including 
cancer site, cancer stage, and cancer treatment type. 
Cancer Staging. The TNM system is one of the most widely used cancer staging 
systems. It is based on the size and extent of the primary tumor (T), the degree of 
spreading to nearby lymph nodes (N), and the presence or absence of metastasis (M). 
A number is added to each letter to indicate the size or extent of primary tumor and 
degree of cancer proliferation. Primary Tumor (T) can be noted as TX (primary tumor 
cannot be evaluated), T0 (no evidence of primary tumor), Tis: Carcinoma in situ (CIS; 
abnormal cells are present, but have not spread to neighboring tissue and may become 
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cancerous), T1, T2, T3, T4 (size and/or extent of the primary tumor). Regional Lymph 
Nodes (N) may be noted as NX: Regional lymph nodes cannot be evaluated, N0: No 
regional lymph node involvement; N1, N2, N3: Degree of regional lymph node 
involvement. Metastasis (M) may be noted as MX: distant metastasis cannot be 
evaluated; M0: no distant metastasis; M1: distant metastasis is present (Greene & 
Sobin, 2002). 
Depression. The Beck Depression Inventory (BDI-II) is a 21-item, self-report rating 
inventory that measures characteristic attitudes and symptoms of depression (Beck, 
Ward, Mendelson, Mock, & Erbaugh, 1961), such as hopelessness and loss of interest. 
Higher scores on the BDI reflect more depressive symptomatology. Internal 
consistency for the BDI ranges from .73 to .92, with a mean of .86 (Beck, Steer, & 
Garbin, 1988). The BDI demonstrates high internal consistency, with alpha 
coefficients of .86 and .81 for psychiatric and non-psychiatric populations, 
respectively (Beck et al., 1988). The BDI-II has been used in a variety of medical and 
healthcare settings, including primary care (Arnau, Meagher, Norris, & Bramson, 
2001; Beck, Guth, Steer, & Ball, 1997), coronary heart disease (Berkman et al., 2006), 
and breast cancer (Love, Grabsch, Clarke, & Kissane, 2004). 
Anxiety. The Beck Anxiety Inventory (BAI) is a 21-item self-report inventory for 
measuring the severity of anxiety, with higher scores reflecting higher anxious 
symptomatology. It has a high internal consistency (α- .92) and test-retest reliability 
over 1 week r(81) = .75. The BAI discriminates anxious diagnostic groups (panic 
disorder, generalized anxiety disorder, etc.) from non-anxious diagnostic groups 
(major depression, dysthymic disorder, etc.). The BAI has been used in various 
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medical and health settings, including bone marrow transplantation (Manne et al., 
2001), coronary artery bypass surgery (Hartford, Wong, & Zakaria, 2002), and chronic 
pulmonary disease (Cully et al., 2006).  
Distress. The National Comprehensive Cancer Network (NCCN) Distress 
Thermometer for Cancer Patients is a self-report measure that has been used to 
identify patients with elevated psychological distress, in various domains, including 
financial, emotional, and physical, with the patients noting subjective levels of 
distress, ranging from 0 (no distress) to 10 (extreme distress) (Goebel & Mehdorn, 
2011; Holland & Bultz, 2007; Jacobsen et al., 2005; Patel, Sharpe, Thewes, Bell, & 
Clarke, 2011). 
Analytic Plan  
All data analyses were conducted using the Statistical Package for the Social 
Sciences, Version 24.0 (SPSS 24.0). First, a series of chi-square tests of independence 
were conducted to determine associations between demographic variables and medical 
characteristics. Second, chi-square tests were run to determine relationships between 
demographic and medical characteristics, and behavioral health program utilization, 
respectively. Finally, repeated-measures within-subjects ANOVAs, with Bonferroni 
corrections, were run to examine changes in depression and/or anxiety between the 
first and second, as well as first and final sessions with behavioral health providers. 
Alpha was established at the .05 level.  
RESULTS 
Demographic and Medical Characteristics 
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From August 2013 to June 2016, a total of 306 patients received cancer 
treatment at the Infusion Therapy Department of the hospital. Behavioral health 
program data was available on 238 patients, representing 77.8% of the total cancer 
patient population. The participants ranged in age from 18 to 95 (Mage = 66.4, SD = 
12.9).  
The majority of the participants (54.2%) identified as female, 45.4% identified 
as male, and 0.4% identified as “other”. The majority (85.7%) of participants 
identified as White, 11.8% identified as Multiracial/ethnic or other, and the remainder 
identified as either Black (.8%), Native American (.4%), Asian (.4%), Hispanic (.4%), 
or Middle Eastern (.4%). The majority (59.2%) of participants were married. 
Additional information regarding patient demographics may be found in Table 1. 
In addition to sociodemographic information, medical information was 
collected. The most common cancer diagnoses were breast (18.1%) and lung (10.1%). 
Further, 19.1% of the sample reported multiple cancer diagnoses, as a result of 
metastasis. Given that 29 different cancer diagnoses were prevalent in the sample, 
variables were recoded such that diagnoses were organized according to organ 
system/site (e.g., gastrointestinal, gynecologic, skin), as presented by the National 
Cancer Institute (2016). This revealed that the most common cancer sites were breast 
(20.4%) and gastrointestinal (16.6%). From the date of program initiation to June 30, 
2016, 17 patients (7.14%) who were offered behavioral health treatment passed away. 
Additional information regarding the sample’s medical characteristics may be found in 
Table 2. 
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Chemotherapy was the most common form of cancer treatment (53.4%), 
followed by receiving two or three forms of treatment (18.4%), surgery (6.3%), and 
radiation (4.2%). Other treatments included immunotherapy (.4%), targeted therapy 
(.4%), and homeopathy (.4%). Additional information regarding the participants’ 
cancer treatment may be found in Table 2. 
Treatment Providers 
 Three years of data revealed that of the 125 patients seen by the behavioral 
health providers, the supervisor and PhD-level licensed psychologist met with the 
majority (34.3%, n = 43) of patients. During the first year of the behavioral health 
program (2013-2014 academic year), two doctoral Psychology students saw 32.8% (n 
= 41) of patients, combined. During the 2014-2015 academic year, two second-year 
and one fourth-year Psychology student saw 26.4% of patients (n = 33). Two students 
joined the behavioral health staff during the 2015-2016 academic year and saw 8 
patients, combined (6.4%). 
Evaluation 
Well-being 
Baseline well-being was assessed using the NCCN, BDI, and BAI. The NCCN 
was administered to a subsample (n = 86) of patients. A score of “3” (minimal to mild 
distress) was the most frequently reported (18.6%), followed by “7” (moderate 
distress; 15.1%). Mean score was 4.36 (SD = 2.63). The BDI was administered to a 
subsample (n = 55) of patients. The mean baseline score was 13.96 (mild depression; 
SD = 13.96, range = 0-43). The BAI was administered to a subsample (n = 46) of 
patients. The mean baseline score was 12.67 (mild anxiety; SD = 9.42, range = 0-39). 
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Program Efficacy 
Change in depression and anxiety scores between patients’ first and last 
sessions was calculated (see Figure 2). For a small subset of patients (n = 17) for 
which follow-up depression scores were available, results revealed that the behavioral 
health program had a statistically significant effect on depression scores between the 
patients’ first (M = 15.29, SD = 6.84) and last (M = 10.47, SD = 6.02) session, F(1,16) 
= 8.5, p = .01, h2 = .35. However, for the small subset of patients (n = 14) for which 
follow-up anxiety scores were available, change in anxiety between the first (M = 
14.29, SD = 10.67) and last (M = 8.86, SD = 6.65) session was not significant, F(1, 14) 
= 2.95, p = .11, h2 = .19. To further evaluate potential treatment gains, change in 
depression and anxiety scores between patients’ first and second sessions was 
calculated. Results revealed that the behavioral health program had a statistically 
significant effect on depression scores, F(1,15) = 4.98, p < .05, h2 = .25, between 
sessions 1 (M = 15.94, SD = 1.63) and 2 (M = 12.94, SD = 1.5). However, results 
revealed that the program’s effects on anxiety scores were not statistically significant, 
F (1,14) = .35, p = .57, h2 = .03, between sessions 1 (M = 14.29, SD = 2.85) and 2 (M 
= 12.14, SD = 2.06). 
Program Utilization 
Of the 238 participants, the majority (68.2%) were referred to STAR® for 
behavioral health services. The range of time between STAR® referral and initial visit 
was zero to 730 days (M = 82.82, SD = 160.53). With regard to overall behavioral 
health service utilization, 49.8% did not initiate treatment or declined to meet with 
behavioral health staff, 23.6% attended one visit, and 26.6% engaged in two or more 
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sessions. The average number of sessions was 2.77 (SD = 8.31, range = 0-96). Chi 
square analyses revealed that those who received a STAR® referral were more likely 
to engage in treatment, compared with those who found out about behavioral health 
services in other ways (e.g., directly approached by behavioral health provider), χ 2 (6) 
= 13.68, p = .03. However, the majority (51.9%) of patients who received a referral 
did not engage in treatment, 20.8% attended one session, and 27.3% engaged in two or 
more. Of the 83 who did not receive a referral, but were offered psychosocial care by 
an oncologist, nurse, or behavioral health provider, 45.8% did not engage, 28.9% 
attended one session, and 25.3% attended two or more. Finally, the majority of 
participants engaged in individual psychosocial care only (50.2%), while five patients 
engaged in support groups only (2.1%), and only 2 patients (0.84%) engaged in both, 
individual and group care. The average number of group sessions attended was .06 
(SD = .43, range = 0-4). 
Demographic Characteristics and Program Utilization 
A series of chi square tests of independence explored relationships between 
demographic variables and behavioral health program utilization. A chi-square test did 
not support an association between gender and treatment acceptance, χ2 (2, n = 237) = 
4.63, p = .10 or between race/ethnicity and treatment acceptance, χ2 (2, n = 237) = 
5.20, p = .07. However, there was an association between being married and accepting 
treatment, χ2 (2, n = 237) = 7.92, p < .001; phi = .55, p < .001 and engaging in at least 
two psychosocial visits, χ2 (2, n = 237) = 3.66, p < .001; phi = .63, <.001. There was 
also an association between being employed and accepting treatment, χ2 (11, n = 237) 
= 52.98, p < .001; phi = .473, p < .001 and engaging in at least two visits, χ2 (22, n = 
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237) = 59.99, p < .001; phi = .503, p < .001. Finally, there was an association between 
being in a younger age group and accepting treatment (compared to those in an older 
age group), χ2 (6, n = 237) = 14.84, p = .02; phi = .26, p = .02. There was also an 
association between being in a younger age group and engaging in at least two 
psychosocial visits, χ2 (3, n = 237) = 10.34, p = .02; phi = .22, p = .01. 
Clinical Characteristics and Program Utilization 
A series of chi square tests of independence revealed relationships between 
clinical characteristics and behavioral health utilization. No relationship between 
cancer organ system site and treatment acceptance was observed, χ2 (22, n = 237) = 
28.96, p = .15. However, a relationship between cancer diagnosis and treatment 
acceptance was observed, χ2 (33, n = 237) = 53.55, p = .01, such that being diagnosed 
with leukemia, lymphoma, multiple myeloma, lung, pancreatic, and gastric cancer was 
associated with accepting treatment, compared with those diagnosed with cancers with 
higher survival rates (e.g., breast; NIH, 2016). Further, there was an association 
between cancer diagnosis and engagement in at least two behavioral health 
encounters, χ2 (66, n = 237) = 87.79, p = .04. The association between treatment 
acceptance and cancer stage was not significant, χ2 (8, n = 237) = 13.87, p = .09. Chi 
square tests revealed between receiving chemotherapy and to accepting treatment, 
compared with those who were receiving multiple cancer treatments, χ2 (10, n = 237) 
= 24.50, p < .01. The association between engaging in at least two sessions and 
receiving only one treatment was also significant, χ2 (20, n = 237) = 37.77, p < .01.  
Baseline Well-Being and Program Utilization 
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 Chi square tests did not support an association between baseline anxiety 
category (e.g., minimal, mild, severe) and treatment acceptance, χ2 (6, n = 237) = 6.84, 
p = .34 or between baseline depression category (e.g., minimal, mild, severe) and 
treatment acceptance, χ2 (6, n = 237) = 5.53, p = .48. Further, the association between 
treatment acceptance and distress level was not significant, χ2 (20, n = 237) = 17.23, p 
= .64. 
DISCUSSION 
Results supported the development, preliminary efficacy, and overall 
utilization of the behavioral health program. As such, the present study provides 
preliminary data and evidence for establishing and maintaining a partnership between 
a hospital and clinical psychology doctoral program. Results may be used to 
benchmark other behavioral health integration efforts. 
Program Development and Implementation 
The behavioral health program was collaboratively designed and implemented, 
with individuals from the hospital and the clinical psychology doctoral program. The 
program and its associated clinical practicum continued to run for the third and fourth 
consecutive year, respectively. The onsite clinical supervisor saw patients and 
provided group and individual supervision. The practicum supervisor leads didactic 
seminars and additional supervision for three-hour sessions, weekly, for the third 
consecutive year. Notably, doctoral students were motivated to lead groups and 
conduct individual sessions in order to accrue clinical hours and to receive intensive 
training and supervision in applications of evidence-based treatments in an oncology 
setting. Consistent with previous studies and recommendations for program 
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development and implementation (Brothers et al., 2015; Williams et al., 2015), the 
present program involved training for all clinicians, in addition to formal supervision. 
Specifically, all clinicians were STAR®-certified and trained in providing evidence-
based treatments (EBTs) for cancer patients. 
Evaluation 
The present study reports only preliminary results on program efficacy. 
Specifically, administering the NCCN was challenging, as nurses were are flooded 
with numerous competing clinical responsibilities, including administering 
medications, fluids, and cancer treatments (including chemotherapy). As such, this 
challenge may be addressed by having oncologists or support staff members 
administer the NCCN during office visits. Although having nurses and oncologists 
administer the measure may address some mental health stigma-related barriers, 
behavioral health providers may administer this measure to all patients receiving 
cancer treatment onsite, in order to maximize distress tracking. “Distress” has been 
defined as a combination of anxiety and depressive symptoms, which may negatively 
influence how patients cope with cancer and their ability to follow treatment 
recommendations (NCCN, 2016). As such, using the NCCN is critical to providing 
comprehensive cancer care, as the vast majority of cancer patients (~95%) do not 
obtain psychological help (NCCN, 2016).    
 Administering the BAI and BDI presented even more challenges. First, only 
behavioral health providers administered these measures, as these measures require 
scoring and categorization into levels of severity. Additionally, the BDI item that 
pertains to suicidality would require behavioral health follow-up, if endorsed by a 
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patient. Second, only patients who accepted treatment completed these measures. The 
majority of patients who declined to complete the BAI and BDI cited fatigue and pain 
as their primary barriers. Consequently, this study lacked a control or comparison 
group, as BAI and BDI scores were not available on patients who declined 
psychosocial treatment. 
Program Efficacy 
Given challenges with BAI and BDI administration, results on changes in 
anxiety and depression were limited, by the small sample size over time. Further, the 
lack of a control or comparison group limited our ability to draw conclusions 
regarding program efficacy. Nonetheless, these preliminary findings are promising 
with regard to intervening on depression among cancer patients. Notably, the present 
study not only revealed significant changes in depression between first and last session 
(i.e., from mild to minimal levels of depression), but between the first and second 
session (e.g., from mild to minimal levels depression). This finding is consistent with 
the psychotherapy literature on large treatment gains that are often observed in the first 
few sessions (Cooper, 2008). However, the present study revealed statistically 
nonsignificant findings with regard to changes on anxiety. Given the unique 
challenges that cancer patients are often faced with, treating anxiety might be 
especially difficult. For instance, addressing concerns related to fear of tumor 
progression and beginning new cancer treatments may be particularly anxiety-
provoking and difficult to address (e.g., Brix et al., 2008). Nonetheless, a clinically 
significant decrease in anxiety was observed (i.e., from mild to minimal levels of 
anxiety).  
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Patient Demographic and Medical Characteristics 
 Consistent with epidemiological data on cancer incidence and prevalence, the 
most common diagnosis in this study sample was breast cancer, followed by lung 
cancer (National Cancer Institute, 2016). Additionally, consistent with national data, 
the majority of individuals in this sample had multiple forms of treatment, often 
surgery as their primary treatment, followed by chemotherapy (National Cancer 
Institute, 2016).  
Program Utilization 
Results revealed promise with regard to behavioral health integration in a 
routine cancer care setting. First, 77.8% of patients receiving cancer treatment were 
offered psychosocial care. This represents a much higher proportion of patients, as 
most other studies revealed substantially lower rates. For instance, Forsythe and 
colleagues (2013) revealed that 55.1% of patients were never offered psychosocial 
care. Notably, this study found that 50.2% patients of patients were willing to engage 
in care, in contrast to another recent study that found that only 4.4% engaged in 
psychosocial care (Forsythe et al., 2013). Additionally, while a previous study 
reported that half of oncologists reported no affiliation with mental health services and 
only 47% made a referral for psychosocial services (Muriel et al., 2015), 68.2% of 
patient received a referral for onsite psychosocial treatment in this study. It is 
important to note that in the present study, over a quarter (26.6%) of patients engaged 
in two or more psychosocial care encounters. Finally, the present study supported the 
use of STAR® referrals to increase psychosocial treatment engagement, as patients 
were more likely to engage in treatment if their referral was generated through the 
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STAR Program®. As such, hospitals offering cancer treatment would benefit from 
acquiring STAR Program® certification. 
In order to evaluate this program and its utilization more broadly, we compared 
its utilization data to that of the general psychotherapy literature. First, the mean 
number of sessions attended in this study was 2.77, ranging from zero to 96 sessions. 
Although it is challenging to make recommendations regarding the number of therapy 
sessions needed to meet criteria for remission or “recovery”, a dose-response 
relationship does exist (Cooper, 2008). However, it is important to note that sudden 
treatment gains on acute and symptomatic problems, as would be expected with a 
cancer patient population, would tend to happen more quickly than change on more 
longstanding problems (i.e., personality-based diagnoses) (e.g., Cooper, 2008; Kopta 
et al., 1994). Notably, although the average number of sessions that patients engaged 
in was few, research has established a ‘law of diminishing returns’, meaning that as 
patients have more sessions, the added benefit of each session actually begins to 
decrease (Cooper, 2008). To illustrate, research has revealed that the degree of 
improvement between session 53 and 104 is approximately the same as between 
sessions two and four (Cooper, 2008). The mean number of sessions attended, in the 
present study, was consistent with the general psychotherapy research, which has 
demonstrated that on average, patients drop out after just two sessions (Swift & 
Greenberg, 2012). However, of those who engaged in treatment (n = 119) in the 
present study, 42% attended three or more sessions, 10.9% attended two sessions, and 
47.1% attended only one. The present research revealed that despite the unique 
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challenges that cancer patients face, many committed to more than three sessions, a 
number greater than what has been observed in the general psychotherapy research. 
Demographics and Program Utilization 
 Results revealed some associations between patient demographics and use of 
the behavioral health program. First, individuals who were not married were more 
likely to utilize the program and to engage in two or more visits. Patients who are 
married might be perceiving their spousal support as sufficient enough to decline 
psychosocial treatment. Second, patients who were not employed were more likely to 
accept treatment, suggesting that engaging in psychosocial care may be an additional 
and demanding time commitment, given investment in work and cancer treatment. For 
patients who are employed while receiving cancer treatment, providing “bedside” 
psychosocial care may be especially important, in order to eliminate or minimize the 
time commitment related to psychosocial care. Finally, patients who were in a younger 
age group were more likely to engage in psychosocial treatment. This finding may be 
interpreted in the context of mental health stigma and is consistent with previous 
research findings on mental health stigma among older age groups (e.g., Brenes et al., 
2015; Conner et al., 2010; Sirey et al., 2001). Strategies to address this stigma may 
include psychoeducation and having oncologists or nurses introduce behavioral health 
services and its providers. Interestingly, analyses revealed no gender differences with 
regard to treatment utilization. This finding is contrary to previous findings in which 
men were less likely to seek or accept psychosocial care (Clement et al., 2015; Vogel 
et al., 2014). 
Clinical Characteristics and Program Utilization 
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Results revealed some associations, with regard to patient clinical 
characteristics and use of the behavioral health program. First, a relationship between 
cancer diagnosis and treatment acceptance and engagement in two or more visits, was 
observed, such that those with multiple cancer diagnoses, due to metastasis, were more 
likely to decline treatment. Further, patients with leukemia, lung cancer, lymphoma, 
multiple myeloma, pancreatic, and gastric cancer were more likely to decline 
treatment. This finding may be due to decreased survival rates for the aforementioned 
cancers (CDC, 2016; NIH, 2016), compared with cancers with higher survival rates 
(e.g., breast), for which patients were more likely to accept psychosocial treatment. 
Given that severe levels of psychological distress may interfere with coping and 
cancer treatment recommendations, it may be especially important for cancer 
treatment providers (oncologists, nurses) to encourage and support psychosocial care 
for these individuals. Second, results revealed that patients who were receiving 
chemotherapy were more likely to engage in psychosocial care than patients receiving 
multiple cancer treatments (e.g., chemotherapy, radiation). Providing “bedside” 
psychosocial care may address this barrier, as patients can have individual therapy 
sessions while receiving chemotherapy, thereby minimizing time commitment. 
Limitations and Future Directions 
This study has several limitations. First, only a small subset of the sample had 
baseline well-being data available. An even smaller subset of the sample had follow-
up well-being data available. Future research should implement a systematic approach 
to progress monitoring, in order to maximize well-being assessment. Second, present 
findings are based on a sample that is mainly White and non-Hispanic. Given the 
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differences in mental health stigma among non-White populations (Nadeem et al., 
2007), additional research examining the utilization of psychosocial services in non-
White populations is warranted. Third, no anxiety or depression data was available on 
patients who declined psychosocial care, thereby limiting our ability to compare 
groups. Fourth, although the behavioral health program is a segment of the STAR® 
program that sought to provide comprehensive care, this program was fundamentally 
not integrated. Specifically, oncologists were often not in contact with behavioral 
health providers past the initial referral, demonstrating separate, rather than integrated 
care (Eickmeyer et al., 2013). This, and other programs, should seek to provide an 
integrated approach, such that oncologists and behavioral health providers exchange 
clinical data regarding shared patients. Conducting weekly team rounds would be an 
excellent platform for exchanging crucial patient information that can inform and 
tailor treatment. Despite its limitations, the study has numerous strengths and may be 
used to guide future investigations and designs of behavioral health programs. First, 
this program represents an important step towards improved integration of patient 
care, using a multidisciplinary care approach to treatment, with enhanced access to 
psychosocial services and care. Given that psychosocial care of cancer patients has 
traditionally been viewed as separate from routine medical care, the present study 
assessed and evaluated the implementation of a more comprehensive approach to 
cancer. This study also implemented monitoring and maximization of treatment 
engagement. Notably, the present investigation exemplified clinical research by 
evaluating a newly developed program for cancer patients. Further, evaluation is 
paramount to using data to improve and further develop a program. In sum, this data 
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may be used to not only further develop the existing program, but to inform program 
development in other settings. Finally, given low engagement rates, this study 
underscores the importance of readiness to change, by way of engaging patients in 
psychosocial care. Future studies should examine barriers to engaging in care and 
should develop measures to evaluate readiness.  
Conclusions 
This study illustrated the feasibility of integrating a behavioral health program 
into routine cancer care and generated several recommendations. First, distress 
tracking may be improved by having the entire team administering measures, 
including nurses, oncologists, and behavioral health providers. Second, partnerships 
between clinical psychology doctoral programs and hospitals, providing cancer care, 
may be mutually beneficial. Third, hospitals offering cancer treatment may benefit 
from acquiring STAR® certification, in order to generate referrals for cancer care that 
is more comprehensive. Treatment that incorporates psychosocial care may be used as 
complementary support for patients diagnosed and treated for cancer. Taken together, 
implementing these recommendations may improve patient physiological and 
psychological outcomes. Finally, this study may serve as a prototype for developing 
such programs and the data can benchmark the success of efforts to improve access to 
cancer-related psychosocial care. 
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Table 1. 
 
Baseline Characteristics 
 
Variable Participants 
Sex % (n) 
     Female 54.2% (n=129) 
     Male 45.4% (n=108) 
    Other .4% (n=1) 
Age  
     18-34 1.9% (n=4) 
     35-49 6% (n=13) 
     50-64 35.8% (n=77) 
     65+ 56.3% (n=121) 
Race/Ethnicity 
      White 85.7% (n=204) 
     Multiracial/Other 11.8% (n=28) 
     Black .8% (n=2) 
     Native American .4% (n=1) 
     Asian/Pacific Islander .4% (n=1) 
     Hispanic/Latino .4% (n=1) 
     Middle Eastern .4% (n=1) 
Marital Status 
      Married 59.2% (n=141) 
     Not married 13.1% (n=31) 
     Divorced 11.3% (n = 27) 
     Widowed 8.8% (n=21) 
     Not Reported 4.6% (n=11) 
     Living with partner 2.1% (n=5) 
     Separated 0.8% (n=2) 
Employment Status 
      Retired 34.5% (n=82) 
     Not Reported 33.6% (n=80) 
     Employed 16% (n=38) 
     Disabled/On Leave 9.6% (n=23) 
     Unemployed 5.5% (n=13) 
     Student 0.8% (n = 2) 
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Table 2. 
Clinical Characteristics. 
Variable Participants 
STAR Referral % (n) 
     Yes 68.2% (n=150) 
     No 31.9% (n=70) 
Cancer Site 
      Breast  19.5% (n=43) 
     Digestive/Gastrointestinal  16% (n=35) 
     Endocrine/Neuroendocrine  1.3% (n=3) 
     Genitourinary  4.6% (n=10) 
     Gynecologic  2.3% (n=5) 
     Head & Neck  5% (n=11) 
     Hematologic/Blood  13.6% (n=30) 
     Musculoskeletal  0.5% (n=1) 
     Neurologic  1.8% (n=4) 
     Respiratory/Thoracic  11.4% (n=25) 
     Skin 1% (n=2) 
     Unknown Primary  4.1% (n=9) 
     Metastasized  19.1% (n=42) 
Cancer Stage 
      0 8.5% (n=17) 
     I 15.6% (n=31) 
     II 14.1% (n=28) 
     III 14.6% (n=29) 
     IV 29.6% (n=59) 
     Unknown 13.6% (n=25) 
     Hematologic 4% (n=8) 
Treatment type 
      Chemotherapy 63.8% (n=127) 
     Homeopathy .5% (n=1) 
     Immunotherapy .5% (n=1) 
     Targeted Therapy .5% (n = 1) 
     Radiation 5% (n=10) 
     Surgery 7.54% (n=15) 
     2 treatments 21.1% (n = 42) 
    3+ treatments 1% (n = 2) 
*Note. Caregivers were not included in the treatment type analysis 
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Figure 1. Flowchart for Referral Process 
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Figure 2.  
 
Depression and Anxiety Scores across Sessions 
 
 
 
 
 
Note. Total BDI and BAI scores across three time points. The solid line shows the 
depression scores, while the dashed line shows the anxiety scores. Change in 
depression scores was significant between the first and second session and between 
the first and final session. Change in anxiety scores was neither significant between 
the first and second session, nor between the first and final session. 
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